
Home / Marketing Audits & Strategy
Built for how cash-pay clinics win patients. Hormone, TRT, longevity, peptide and med spa clinics each market differently, and the gaps repeat.
Book a Strategy CallMany cash-pay clinics run marketing that brings in leads but not patients. The audit finds where: the wrong channel for the category, a cost per lead that looks fine until you divide it by the booking rate, a show rate nobody tracks, or local search that sends patients to a competitor. Our guide to the regenerative health clinic marketing audit walks through each step.
Google requires advertisers to apply before running prescription drug ads, and its cell therapy policy covers stem cell therapy and PRP. A clinic built only on paid ads is one policy change from losing its leads, so ACG plans the organic strategy first. Marketing execution is a separate engagement.
What each lead costs you, by channel, against what a compliant campaign in your category should cost.
How many leads book a consultation, and where they drop off between first contact and appointment.
How many booked consultations attend: a follow-up and lead quality problem many clinics miss until revenue slips.
Which channels bring patients and which bring only volume.
Whether patients searching locally for your services find your clinic or a competitor's.
Which campaigns are at risk under the ad platform rules for your category, and the compliant alternative.
What works for a medical weight loss clinic on Meta does not work for a TRT clinic, and what ranks for a longevity clinic is not what ranks for a med spa. ACG plans hormone, TRT and peptide clinic marketing and longevity clinic SEO around each category's rules.
The local searches your clinic should own, service by service, and the content and citation work that gets it there.
Campaigns planned within the ad platform rules for your category, so they run instead of being disapproved and rebuilt.
The path from first contact to attended visit, mapped step by step to close the gap between leads and patients.
A review plan that builds local trust and search visibility, timed to the patient journey and the platforms patients read.
Word of mouth made repeatable, especially in sexual wellness and hormone health, where many patients would rather ask a friend than click an ad.
Five numbers tracked and acted on: cost per lead, booking rate, show rate, cost per acquired patient and patient lifetime value.
What the audit covers and what ACG plans. Anything else, ask on the strategy call.
View All FAQs
Talk with Grayson Miller about your cost per lead, your booking and show rates and how your clinic type should be marketed, or see client results first. No pitch. No obligation.
ACG is a consulting and advisory firm, not a medical practice; an independent, state-licensed Medical Director directs all clinical care. Results are not guarantees of income. Individual outcomes vary.
Knowing the rules is the foundation of every clinic we help launch.
You own and run the business. An independent, state-licensed Medical Director makes every clinical, prescribing and treatment decision, structured for your state's Corporate Practice of Medicine laws. We connect you to a vetted network; you retain your own provider.
PRP, peptides, GLP-1 medications and cellular products each carry federal and state rules, and not every product or use is FDA-approved. Exosomes for therapeutic use are not FDA-approved at all, and we steer you away from them. Your menu and marketing are built to hold up to FDA, FTC and state medical board scrutiny.
We show real ranges and never promise an income or a clinical outcome. What you earn depends on your market, your capital and your execution.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe or sell any drug, biologic, device or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the compliance of every product, therapy and claim. See the full regulatory notice below.